It looks like the shorters are starting to buy back.The word from my broker is that the company is travelling very well with plenty of pipeline and no need to raise any capital.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024